Homocysteine as a risk factor for hypertension: a 2-year follow-up study.
Homocysteine (Hcy) is regarded as a risk factor for hypertension, but research on the causal relationship between Hcy and hypertension is limited. In the present study, we prospectively tracked the blood pressure progression of a normotensive population with different Hcy levels over a 2-year period...
Main Authors: | Yixuan Wang, Shuohua Chen, Tao Yao, DongQing Li, YanXiu Wang, YuQing Li, ShouLing Wu, Jun Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4195588?pdf=render |
Similar Items
-
Prehypertension and Chronic Kidney Disease in Chinese Population: Four-Year Follow-Up Study.
by: Hao Xue, et al.
Published: (2015-01-01) -
Associations of homocysteine status and homocysteine metabolism enzyme polymorphisms with hypertension and dyslipidemia in a Chinese hypertensive population
by: Xiaojie Yuan, et al.
Published: (2020-01-01) -
Correlation between hypertension and high homocysteine levels caused by the MTHFR C677T gene polymorphisms
by: Jian-Rong Xu, et al.
Published: (2022-04-01) -
Medical foods for lowering homocysteine in hypertensive patients
by: Merrill F. Elias, et al.
Published: (2023-01-01) -
Homocysteine Levels in the Blood Serum of Adolescents with Hypertension
by: M.A. Gonchar, et al.
Published: (2013-04-01)